Adapt Wealth Advisors, LLC

SEC CIK: 0002013937
Latest filing: Aug 12, 2026

SEC filings (opens in a new tab)

CPRX holding history

Catalyst Pharmaceuticals, Inc. in every 13F filed by Adapt Wealth Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CPRX overview All 13F holders of CPRX Full Q2 2026 holdings

Shares (Q2 2026): 7,300
Value: $229.4K
% of portfolio: 0.1%
Quarters held: 3; Since Q4 2025

Holdings of CPRX by Adapt Wealth Advisors, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	7,300	$229.4K	0.1%	−1,700−18.9%	Reduced	Holders
Q1 2026	9,000	$222.8K	0.1%	−100−1.1%	Reduced	Holders
Q4 2025	9,100	$212.4K	0.1%	+9,100	New	Holders